These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27414125)

  • 21. Dosimetric impact of the interplay effect during stereotactic lung radiation therapy delivery using flattening filter-free beams and volumetric modulated arc therapy.
    Ong CL; Dahele M; Slotman BJ; Verbakel WF
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):743-8. PubMed ID: 23773394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereotactic body radiotherapy delivered with IMRT for oligometastatic regional lymph node metastases in hepatocellular carcinoma: a single-institutional study.
    Matoba M; Tsuchiya H; Kondo T; Ota K
    J Radiat Res; 2020 Sep; 61(5):776-783. PubMed ID: 32845298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2).
    Deodato F; Cilla S; Macchia G; Torre G; Caravatta L; Mariano G; Mignogna S; Ferro M; Mattiucci GC; Balducci M; Frascino V; Piermattei A; Ferrandina G; Valentini V; Morganti AG
    Clin Oncol (R Coll Radiol); 2014 Dec; 26(12):748-56. PubMed ID: 25175042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. OLIGOPELVIS - GETUG P07: a multicentre phase II trial of combined salvage radiotherapy and hormone therapy in oligometastatic pelvic node relapses of prostate cancer.
    Supiot S; Rio E; Pacteau V; Mauboussin MH; Campion L; Pein F
    BMC Cancer; 2015 Sep; 15():646. PubMed ID: 26408012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Volumetric modulated arc therapy for thoracic node metastases: a safe and effective treatment for a neglected disease.
    Franceschini D; De Rose F; Fogliata A; Navarria P; Ascolese AM; Franzese C; Comito T; Tozzi A; Iftode C; Di Brina L; D'Agostino G; Clerici E; Cozzi L; Scorsetti M
    Oncotarget; 2016 Aug; 7(33):53321-53329. PubMed ID: 27462869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Robotic Stereotactic Body Radiation Therapy in Patients With Recurrent or Metastatic Abdominopelvic Tumors: A Single Institute Experience.
    Sezen D; Gurkaynak M; Gultekin M; Cengiz M; Yildiz F; Zorlu F; Akyol F; Yazici G; Hurmuz P; Ozyigit G
    Technol Cancer Res Treat; 2016 Feb; 15(1):203-11. PubMed ID: 25687510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Volumetric modulated arc therapy versus conventional intensity modulated radiation therapy for stereotactic spine radiotherapy: a planning study and early clinical data.
    Kuijper IT; Dahele M; Senan S; Verbakel WF
    Radiother Oncol; 2010 Feb; 94(2):224-8. PubMed ID: 20122745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of high-dose-rate stereotactic body radiotherapy.
    Stieb S; Lang S; Linsenmeier C; Graydon S; Riesterer O
    Radiat Oncol; 2015 Jan; 10():27. PubMed ID: 25614416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of RapidArc volumetric-modulated arc therapy to deliver stereotactic radiosurgery and stereotactic body radiotherapy to intracranial and extracranial targets.
    Roa DE; Schiffner DC; Zhang J; Dietrich SN; Kuo JV; Wong J; Ramsinghani NS; Al-Ghazi MS
    Med Dosim; 2012; 37(3):257-64. PubMed ID: 22365418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma.
    Navarria P; Ascolese AM; Cozzi L; Tomatis S; D'Agostino GR; De Rose F; De Sanctis R; Marrari A; Santoro A; Fogliata A; Cariboni U; Alloisio M; Quagliuolo V; Scorsetti M
    Eur J Cancer; 2015 Mar; 51(5):668-74. PubMed ID: 25686482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
    Seco J; Gu G; Marcelos T; Kooy H; Willers H
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcome of dose-escalated image-guided radiotherapy for spinal metastases.
    Guckenberger M; Goebel J; Wilbert J; Baier K; Richter A; Sweeney RA; Bratengeier K; Flentje M
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):828-35. PubMed ID: 19250762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy.
    Myrehaug S; Chan G; Craig T; Weinberg V; Cheng C; Roach M; Cheung P; Sahgal A
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e657-62. PubMed ID: 22245189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fractionated stereotactic radiosurgery with volumetric modulated arc therapy (Rapid Arc) for reradiation in recurrent high grade gliomas.
    Anand AK; Kumar P; Patir R; Vaishya S; Bansal AK; Chaudhoory AR; Punnakal AU; Malhotra H; Munjal RK
    J Cancer Res Ther; 2014; 10(1):97-102. PubMed ID: 24762494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CyberKnife Stereotactic Ablative Radiotherapy as an Option of Treatment for Patients With Prostate Cancer Having Oligometastatic Lymph Nodes: Single-Center Study Outcome Evaluation.
    Napieralska A; Miszczyk L; Stąpór-Fudzińska M
    Technol Cancer Res Treat; 2016 Oct; 15(5):661-73. PubMed ID: 26208835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control.
    Videtic GM; Stephans K; Reddy C; Gajdos S; Kolar M; Clouser E; Djemil T
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):344-9. PubMed ID: 19765913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereotactic Body Radiation Therapy (SBRT) in Pelvic Lymph Node Oligometastases.
    Reshko LB; Richardson MK; Spencer K; Kersh CR
    Cancer Invest; 2020 Nov; 38(10):599-607. PubMed ID: 32715780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Volumetric modulation arc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for advanced esophageal cancer: a feasibility study.
    Nicolini G; Ghosh-Laskar S; Shrivastava SK; Banerjee S; Chaudhary S; Agarwal JP; Munshi A; Clivio A; Fogliata A; Mancosu P; Vanetti E; Cozzi L
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):553-60. PubMed ID: 22386376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer.
    Fonteyne V; De Gersem W; De Neve W; Jacobs F; Lumen N; Vandecasteele K; Villeirs G; De Meerleer G
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1013-20. PubMed ID: 19386427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancer.
    Jereczek-Fossa BA; Fariselli L; Beltramo G; Catalano G; Serafini F; Garibaldi C; Cambria R; Brait L; Possanzini M; Bianchi LC; Vavassori A; Zerini D; Orsi F; de Cobelli O; Orecchia R
    Radiother Oncol; 2009 Oct; 93(1):14-7. PubMed ID: 19409636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.